1
|
Wang W, Wang J, Li J, Yan P, Jin Y, Zhang R, Yue W, Guo Q, Geng J. Cholecystectomy Damages Aging-Associated Intestinal Microbiota Construction. Front Microbiol 2018; 9:1402. [PMID: 29988510 PMCID: PMC6026649 DOI: 10.3389/fmicb.2018.01402] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2018] [Accepted: 06/07/2018] [Indexed: 12/12/2022] Open
Abstract
The intestinal microbiome is essential in humans to maintain physiological balance and nutrition metabolism. Laparoscopic cholecystectomy due to gallstone disease and cholecystitis can cause intestinal microbial dysbiosis, and following bile acid metabolism dysfunction, positions the patient at high risk of colorectal cancer. However, little is known regarding intestinal microbiota characteristics in post-cholecystectomy patients. Here, we compared the microbial composition of cholecystectomy patients with that of a healthy population. We determined that cholecystectomy eliminated aging-associated fecal commensal microbiota and further identified several bile acid metabolism-related bacteria as contributors of colorectal cancer incidence via elevation of secondary bile acids.
Collapse
Affiliation(s)
- Wenxue Wang
- Department of Infectious Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.,Kunming University of Science and Technology, Kunming, China
| | - Junfeng Wang
- Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming, China
| | - Julan Li
- Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, China
| | - Pingping Yan
- Department of Infectious Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China
| | - Yun Jin
- Department of Hepatobiliary Surgery, The First People's Hospital of Yunnan Province, Kunming, China
| | - Ruyi Zhang
- Department of Infectious Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China
| | - Wei Yue
- Department of Infectious Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China
| | - Qiang Guo
- Department of Gastroenterology, The First People's Hospital of Yunnan Province, Kunming, China
| | - Jiawei Geng
- Department of Infectious Diseases, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China
| |
Collapse
|
2
|
São Julião GP, Habr-Gama A, Vailati BB, Aguilar PB, Sabbaga J, Araújo SEA, Mattacheo A, Alexandre FA, Fernandez LM, Gomes DB, Gama-Rodrigues J, Perez RO. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer? Eur J Surg Oncol 2017; 44:93-99. [PMID: 29217398 DOI: 10.1016/j.ejso.2017.11.010] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2017] [Revised: 10/10/2017] [Accepted: 11/16/2017] [Indexed: 10/18/2022] Open
Abstract
Patients with cT3 rectal cancer are less likely to develop complete response to neoadjuvant chemoradiation (nCRT) and still face significant risk for systemic relapse. In this setting, radiation (RT) dose-escalation and consolidation chemotherapy in "extended" nCRT regimens have been suggested to improve primary tumor response and decrease the risks of systemic recurrences. For these reasons we compared surgery-free and distant-metastases free survival among cT3 patients undergoing standard or extended nCRT. METHODS Patients with distal and non-metastatic T3 rectal cancer managed by nCRT were retrospectively reviewed. Patients undergoing standard CRT (50.4 Gy and 2 cycles of 5FU-based chemotherapy) were compared to those undergoing extended CRT (54 Gy and 6 cycles of 5FU-based chemotherapy). Patients were assessed for tumor response at 8-10 weeks. Patients with complete clinical response (cCR) underwent organ-preservation strategy (Watch & Wait). Patients were referred to salvage surgery in the event of local recurrence during follow-up. Cox's logistic regression was performed to identify independent features associated with improved surgery-free survival after cCR and distant-metastases-free survival. RESULTS 155 patients underwent standard and 66 patients extended CRT. Patients undergoing extended CRT were more likely to harbor larger initial tumor size (p = 0.04), baseline nodal metastases (cN+; p < 0.001) and higher tumor location (p = 0.02). Cox-regression analysis revealed that the type of nCRT regimen was not independently associated with distinct surgery-free survival after cCR or distant-metastases-free survival (p > 0.05). CONCLUSIONS Dose-escalation and consolidation chemotherapy are insufficient to increase long-term surgery-free survival among cT3 rectal cancer patients and provides no advantage in distant metastases-free survival.
Collapse
Affiliation(s)
| | - Angelita Habr-Gama
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Bruna Borba Vailati
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Patricia Bailão Aguilar
- Hospital Alemão Oswaldo Cruz - Radiation Oncology, Rua Joao Juliao, 331, Sao Paulo, SP, 01323-020, Brazil
| | - Jorge Sabbaga
- Centro de Oncologia Molecular - Hospital Sirio-Libanês, Rua Dona Adma Jafet, 91, Sao Paulo, SP, 01308-050, Brazil
| | - Sérgio Eduardo Alonso Araújo
- University of São Paulo School of Medicine, Colorectal Surgery Division, Av. Dr. Arnaldo, 455, Sao Paulo, SP, 01246-903, Brazil; Hospital Israelita Albert Einstein, Av. Albert Einstein, 627, Sao Paulo, SP, 05652-900, Brazil
| | - Adrian Mattacheo
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Flavia Andrea Alexandre
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Laura Melina Fernandez
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Diogo Bugano Gomes
- Hospital Israelita Albert Einstein, Av. Albert Einstein, 627, Sao Paulo, SP, 05652-900, Brazil
| | - Joaquim Gama-Rodrigues
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil
| | - Rodrigo Oliva Perez
- Angelita & Joaquim Gama Institute, Rua Manoel da Nobrega, 1564, Sao Paulo, SP, 04001-005, Brazil; University of São Paulo School of Medicine, Colorectal Surgery Division, Av. Dr. Arnaldo, 455, Sao Paulo, SP, 01246-903, Brazil; Ludwig Institute for Cancer Research São Paulo Branch, Rua Dona Adma Jafet, 91, Sao Paulo, SP, 01308-050, Brazil.
| |
Collapse
|